Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 504

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 504
---
 registration statement covering the resale of the shares issuable upon the exercise of the warrants, on a cashless basis. The TuHURA Common Warrants contain customary adjustments to the exercise price and number of underlying warrant shares by reason of stock splits, stock dividends, reverse stock split, and the like.

In connection with the TuHURA Note Financing, TuHURA issued an aggregate of approximately 0.1 million shares of Legacy TuHURA common stock (as adjusted by the exchange ratio in the Kintara merger) to a placement agent for the private placement of the TuHURA Note Financing.**

<div align='center'>311</div>

Private Placement of Common Stock In July 2024, TuHURA sold 0.7 million shares of Legacy TuHURA common stock in a private offering with a purchase price of $5,000,000 to an existing stockholder. Warrant Exercise Notes On February 12, 2025, four holders (the “Makers”) of common stock purchase warrants (the “Warrants”) of TuHURA made and issued to TuHURA secured promissory notes (the “Warrant Exercise Notes”) in the aggregate principal amount of $3,011,373 as payment of the exercise price of an aggregate of 1,034,836 Warrants held by the Makers. The Makers were comprised of KP Biotech Group, LLC, CA Patel F&F Investments, LLC, Dr. Kiran C. Patel and Donald Wojnowski. Upon the exercise of the Warrants, TuHURA issued to the Makers an aggregate of 1,034,836 Warrant Shares, all of which are “restricted securities” within the meaning of the federal securities laws. The Warrant Exercise Notes are due and payable on May 30, 2025. Cash Flows The following table sets forth a summary of the net cash flow activity for the years ended December 31, 2024 and 2023, respectively:

|                                 |     | Year Ended December 31, 
 2024                    |             |   |     | 2023 |             |   |
|:--------------------------------|:----|:------------------------|------------:|:--|:----|:-----|------------:|:--|
| Net cash provided by (used in): |     |                         |             |   |     |      |             |   |
| Operating activities            |     | $                       | (14,728,138 | ) |     |